November 12, 2021
November 9, 2021 at 12:00 pm
The intersection of COVID-19 and substance use represents the confluence of two severe public health crises, with the COVID-19 pandemic compounding the ongoing opioid crisis. There is a clear increased risk of harm to people who use drugs or who have a substance use disorder in the COVID-19 context due to self-isolation requirements, physical distancing measures, and/or an increasingly toxic illegal drug supply. CIHR is launching this evaluation-focused funding opportunity to address harm reduction approaches to the opioid crisis and to better understand its compounding intersection with the COVID-19 pandemic.
Proposal Development Support
For support in preparing a UBCO-led application, please get in touch with the contact below:
How to Apply